- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 409/02 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
Patent holdings for IPC class C07D 409/02
Total number of patents in this class: 105
10-year publication summary
9
|
4
|
9
|
9
|
8
|
6
|
2
|
5
|
3
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
MyoKardia, Inc. | 107 |
5 |
Merck Patent GmbH | 5831 |
4 |
Allergan, Inc. | 2349 |
4 |
Rohm and Haas Electronic Materials Korea Ltd. | 330 |
4 |
Janssen Pharmaceutica N.V. | 3392 |
3 |
Sanford Burnham Prebys Medical Discovery Institute | 300 |
3 |
FUJIFILM Corporation | 29367 |
2 |
Idemitsu Kosan Co., Ltd. | 4219 |
2 |
CalciMedica, Inc. | 81 |
2 |
Jiangsu Hengrui Medicine Co., Ltd. | 706 |
2 |
Phillips 66 Company | 1054 |
2 |
Shanghai Hengrui Pharmaceutical Co., Ltd. | 644 |
2 |
Solarmer Energy, Inc. | 10 |
2 |
Vanderbilt University | 1901 |
2 |
Synnovation Therapeutics, Inc. | 17 |
2 |
Bristol-myers Squibb Company | 4898 |
1 |
F. Hoffmann-La Roche AG | 7925 |
1 |
BASF SE | 20933 |
1 |
Genentech, Inc. | 3976 |
1 |
Boehringer Ingelheim International GmbH | 4650 |
1 |
Other owners | 59 |